Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Bijnens

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Bioscience (Elite Edition)|December 29, 2009
Application and review of the separate ray model to investigate interaction effectsRoel Straetemans, Luc Bijnens
Briefings in Bioinformatics|October 3, 2017
A broken promise: microbiome differential abundance methods do not control the false discovery rateStijn Hawinkel, Federico Mattiello, Luc Bijnens, et al.
Plos One|February 14, 2019
A unified framework for unconstrained and constrained ordination of microbiome read count dataStijn Hawinkel, Frederiek-Maarten Kerckhof, Luc Bijnens, et al.
Pharmaceutical Statistics|November 26, 2014
Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery processAriel Alonso, Elasma Milanzi, Geert Molenberghs, et al.
Plos One|May 1, 2020
Sequence count data are poorly fit by the negative binomial distributionStijn Hawinkel, J C W Rayner, Luc Bijnens, et al.
Statistics in Medicine|April 5, 2002
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-outBart Michiels, Geert Molenberghs, Luc Bijnens, et al.
Statistics in Medicine|February 24, 2015
A new modeling approach for quantifying expert opinion in the drug discovery processAriel Alonso, Elasma Milanzi, Geert Molenberghs, et al.
NAR Genomics and Bioinformatics|February 12, 2021
Model-based joint visualization of multiple compositional omics datasetsStijn Hawinkel, Luc Bijnens, Kim-Anh Lê Cao, et al.
Journal of Biopharmaceutical Statistics|March 31, 2005
A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependentZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Journal of Biopharmaceutical Statistics|May 25, 2010
A latent pharmacokinetic time profile to model dose-response survival dataTom Jacobs, Roel Straetemans, Geert Molenberghs, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Bioscience (Elite Edition)|December 29, 2009
Application and review of the separate ray model to investigate interaction effectsRoel Straetemans, Luc Bijnens
Briefings in Bioinformatics|October 3, 2017
A broken promise: microbiome differential abundance methods do not control the false discovery rateStijn Hawinkel, Federico Mattiello, Luc Bijnens, et al.
Plos One|February 14, 2019
A unified framework for unconstrained and constrained ordination of microbiome read count dataStijn Hawinkel, Frederiek-Maarten Kerckhof, Luc Bijnens, et al.
Pharmaceutical Statistics|November 26, 2014
Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery processAriel Alonso, Elasma Milanzi, Geert Molenberghs, et al.
Plos One|May 1, 2020
Sequence count data are poorly fit by the negative binomial distributionStijn Hawinkel, J C W Rayner, Luc Bijnens, et al.
Statistics in Medicine|April 5, 2002
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-outBart Michiels, Geert Molenberghs, Luc Bijnens, et al.
Statistics in Medicine|February 24, 2015
A new modeling approach for quantifying expert opinion in the drug discovery processAriel Alonso, Elasma Milanzi, Geert Molenberghs, et al.
NAR Genomics and Bioinformatics|February 12, 2021
Model-based joint visualization of multiple compositional omics datasetsStijn Hawinkel, Luc Bijnens, Kim-Anh Lê Cao, et al.
Journal of Biopharmaceutical Statistics|March 31, 2005
A hierarchical Binomial-Poisson model for the analysis of a crossover design for correlated binary data when the number of trials is dose-dependentZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.
Journal of Biopharmaceutical Statistics|May 25, 2010
A latent pharmacokinetic time profile to model dose-response survival dataTom Jacobs, Roel Straetemans, Geert Molenberghs, et al.
Pageof 5